Profiel
Tomas Leanderson is a Professor of Immunology at the University of Lund, where he has been employed since 1990.
He was previously the President, Co-Chief Executive Officer, and IR Contact at Active Biotech AB from 2008 to 2017.
He also served as a Director at ProNoxis AB. Leanderson earned a doctorate degree from Umea Universitet.
Actieve functies van Tomas Leanderson
| Bedrijven | Functie | Begin |
|---|---|---|
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 06-05-2010 |
Eerdere bekende functies van Tomas Leanderson
| Bedrijven | Functie | Einde |
|---|---|---|
| ACTIVE BIOTECH AB | Algemeen Directeur | 01-07-2017 |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Directeur/Bestuurslid | - |
Opleiding van Tomas Leanderson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Active Biotech AB
Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Health Technology |
















